Monthly Archives: October 2014

Clinical Trial to Evaluate Two Biothera Cancer Drugs for Advanced Pancreatic Cancer

EAGAN, MN — October 23, 2014 — A phase 1b clinical trial at the University of Illinois at Chicago (UIC) will evaluate a new combination therapy for advanced pancreatic cancer that includes two Biothera cancer immunotherapy drug candidates. The investigator-sponsored study combines Biothera’s Imprime PGG® and mucin-1 (MUC1) targeted monoclonal antibody BTH1704 with the chemotherapy gemcitabine (Gemzar®) in patients with advanced, previously treated pancreatic ductal...

Read More